• Talabostat Mesylate (PT-100): A Precision Tool for Tumor Mic

  2026-05-24

  Explore how Talabostat mesylate (PT-100) enables precise modulation of the tumor microenvironment by targeting DPP4 and FAP, with unique insights on assay design and neuroimmune research applications. Discover distinctive protocol guidance and translational relevance beyond conventional reviews.

• Anti Reverse Cap Analog: Boosting mRNA Translation Efficienc

  2026-05-23

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, delivers orientation-specific capping for synthetic mRNA, nearly doubling translational efficiency compared to conventional analogs. Learn how APExBIO’s ARCA empowers mRNA therapeutics research with robust protocols, troubleshooting guidance, and experimental insights.

• Cleavage-Resistant TREM2 Enhances Macrophage Efferocytosis i

  2026-05-22

  Dong et al. developed a synthetic TREM2 variant resistant to ADAM17-mediated cleavage, restoring efferocytosis and reducing inflammation in mouse models of MASH and atherosclerosis. This work demonstrates the potential of engineering receptor stability to overcome proteolytic regulation and improve macrophage function in inflammatory diseases.

• ECL Western Blotting Substrate: Technical Workflow Guide

  2026-05-22

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive chemiluminescent solution for the detection of horseradish peroxidase-conjugated proteins in Western blot assays. It is optimized for molecular biology, cancer biology, and signal transduction pathway research, but is not suitable for fluorescent or radioisotopic detection workflows.

• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-05-21

  This study introduces a combinatorial library of biodegradable, ROS-responsive lipid nanoparticles that selectively deliver mRNA to tumor cells, enabling efficient disruption of mutant RAS signaling. The findings highlight a promising strategy for targeted mRNA therapeutics by leveraging tumor-specific intracellular environments.

• Luminescent ATP Cell Viability Assay Kit I: Precision in Fer

  2026-05-21

  The Luminescent ATP Cell Viability Assay Kit I empowers researchers with ultra-sensitive, rapid cell viability measurement using luciferase luminescence detection. Its streamlined workflow and robust performance make it an essential tool for dissecting ferroptosis, cytotoxicity, and metabolic responses in complex disease models.

• N1-Methylpseudouridine: Shaping mRNA Translation for Metabol

  2026-05-20

  Explore how N1-Methylpseudouridine, a leading modified nucleoside, is advancing mRNA translation enhancement and metabolic regulation research. This article uniquely connects translational control with mitochondrial metabolism, providing advanced insights for assay optimization.

• PML Drives Osteogenic Differentiation via HIF1AN Ubiquitinat

  2026-05-20

  The referenced study elucidates how promyelocytic leukemia protein (PML) enhances osteogenic differentiation in bone marrow mesenchymal stem cells (BMSCs) by promoting HIF1AN ubiquitination and activating the PI3K/AKT pathway. This mechanistic insight identifies PML as a pivotal regulator in osteoporosis-related bone formation and highlights potential molecular targets for regenerative therapies.

• Pathogen-Driven Discovery of Host Mediators in Macrophage Ba

  2026-05-19

  Russell et al. introduce a pathogen-centric approach to uncover how hypervirulent Streptococcus pneumoniae evade macrophage killing, identifying host factors such as NAMPT and P2RX7 as essential mediators. These findings provide a new framework for host-directed therapy development and inform experimental design in immunology and infectious disease research.

• Optimizing Neuroblastoma Research with AZD3463 ALK/IGF1R Inh

  2026-05-19

  AZD3463 stands out as a dual ALK/IGF1R inhibitor, enabling reproducible apoptosis induction and combination therapy optimization in neuroblastoma research. This guide delivers actionable workflows, troubleshooting tips, and evidence-backed protocol parameters for advanced cancer model studies.

• SlSLAH1-Mediated Malate Exudation Enables Aluminium Toleranc

  2026-05-18

  This study identifies the anion channel SlSLAH1 as a key plasma membrane transporter driving malate exudation and aluminium tolerance in tomato. By elucidating the regulatory module linking Al-induced transcriptional activation (SlSTOP1-SlSZP1) to efflux of malate, the research advances mechanistic understanding and suggests targets for improving crop resilience in acidic soils.

• Capecitabine in Precision Oncology: Beyond Tumor Models

  2026-05-18

  Explore the advanced role of Capecitabine, a fluoropyrimidine prodrug, in precision oncology research. This article reveals how its unique activation and apoptosis pathways enable deeper insights and robust assay decisions, offering perspectives beyond conventional tumor model applications.

• S-Adenosylmethionine (SAM): Systems Biology of Methylation

  2026-05-17

  Explore how S-Adenosylmethionine (SAM) shapes cellular methylation networks, bridging metabolic, epigenetic, and neurological research. This article uncovers multi-omic assay strategies and translational insights unique to SAM’s systems-level functions.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking Tool

  2026-05-16

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) is a dual-reporter mRNA engineered for real-time visualization of mRNA delivery and gene expression in mammalian systems. Its Cap1 capping, Cy5 labeling, and 5-moUTP modification enable high translation efficiency, reduced immunogenicity, and robust bioluminescence imaging. This product supports advanced applications in mRNA delivery, transfection optimization, and immune-silent tracking.

• (R,S)-Anatabine (SKU C4859): Precision for Aβ & Cell Viabili

  2026-05-15

  This article explores how (R,S)-Anatabine (SKU C4859) from APExBIO addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays within neurodegeneration research. Through scenario-driven analysis, we highlight its validated mechanisms—soluble Aβ reduction, BACE-1 and NF-κB inhibition—and provide actionable guidance on experimental design, protocol optimization, and supplier reliability.

399 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page